Literature DB >> 439776

Renal and vascular activity of prolactin preparations. Contamination of prolactin preparations with ADH and implications on renal and vascular prolactin research.

H Vorherr.   

Abstract

Prolactin, as a "broad spectrum hormone", has been described to exert also vascular and renal actions in laboratory animals and in humans. However, prolactin preparations of various species are contaminated with neurohypophysial hormones (ADH, oxytocin) which possess vascular and renal activities. Antisera against ADH, oxytocin and prolactin are rather specific inactivators of the biologic activity of the respective hormone; the oxytocinasevasopressinase system of pregnancy plasma destroys ADH and oxytocin. Incubation-identification procedures with antisera against ADH, oxytocin and prolactin and with pregnancy plasma revealed that changes in blood pressure, urine flow and urinary osmolarity cannot be ascribed to prolactin per se but to the ADH impurity of prolactin preparations. Furthermore, recent metabolic studies in normally hydrated, overhydrate and dehydrated animals and humans have shown that prolactin does not affect renal water and electrolyte excretion. Thus, earlier reports on vascular and renal activity of prolactin in laboratory animals and humans should be viewed with great caution. Elimination of neurohypophysial hormone impurities of prolactin preparations by incubation with either ADH and oxytocin antisera or with pregnancy plasma provides techniques for better assessment of the real biologic effects of the prolactin molecule.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 439776     DOI: 10.1007/bf01476049

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  39 in total

1.  Evidence for vasopressin contamination of ovine and bovine prolactin.

Authors:  W B Malarkey; J M George; R W Baehler
Journal:  IRCS J Med Sci       Date:  1975-06

2.  A device for estimating blood-pressure in the rabbit.

Authors:  R T Grant; P Rothschild
Journal:  J Physiol       Date:  1934-05-21       Impact factor: 5.182

3.  Circulatory changes following prolactin administration.

Authors:  E E Bryant; B H Douglas; A D Ashburn
Journal:  Am J Obstet Gynecol       Date:  1973-01-01       Impact factor: 8.661

4.  "Trace" contamination of corticotropin and human growth hormone with vasopressin--clinical significance.

Authors:  G Baumann; E J Rayfield; L I Rose; G H Williams; J F Dingman
Journal:  J Clin Endocrinol Metab       Date:  1972-05       Impact factor: 5.958

5.  Actions of prolactin on human renal function.

Authors:  D F Horrobin; I J Lloyd; A Lipton; P G Burstyn; N Durkin; K L Muiruri
Journal:  Lancet       Date:  1971-08-14       Impact factor: 79.321

Review 6.  Human prolactin.

Authors:  W H Daughaday; L S Jacobs
Journal:  Ergeb Physiol       Date:  1972

7.  Effect of intravenous prolactin infusion on arterial blood pressure in rabbits.

Authors:  D F Horrobin; M S Manku; P G Burstyn
Journal:  Cardiovasc Res       Date:  1973-09       Impact factor: 10.787

8.  Identification of neurohypophysial hormones with their antisera.

Authors:  H Vorherr; R A Munsick
Journal:  J Clin Invest       Date:  1970-04       Impact factor: 14.808

9.  Failure of oral water loading and intravenous hypotonic saline to suppress plasma prolactin in man.

Authors:  R A Adler; G L Noel; L Wartofsky; A G Frantz
Journal:  J Clin Endocrinol Metab       Date:  1975-08       Impact factor: 5.958

10.  Prolactin and hypertension.

Authors:  J K Mati; M Mugambi; W S Odipo; K Nguli
Journal:  Am J Obstet Gynecol       Date:  1977-03-15       Impact factor: 8.661

View more
  1 in total

1.  Acute and chronic effects of progesterone and prolactin on renal function in the rat.

Authors:  A O Elkarib; H O Garland; R Green
Journal:  J Physiol       Date:  1983-04       Impact factor: 5.182

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.